Industry News
Former telco ventures into biotech with Burnet deal
Former telecommunications company Select-Tel is the latest to venture into biotech, signing a memorandum of understanding with Melbourne's MacFarlane Burnet Institute for Medical Research and Public Health to commercialise several projects from the Institute. [ + ]
Qld steps up east-coast biotech powerhouse campaign
A proposal by Queensland Premier Peter Beattie to join biotechnology forces with Victoria and NSW is receiving a positive response from NSW Premier Bob Carr. [ + ]
New genetic theory claims epileptics may cop a double whammy
Some individuals born into families with a history of epilepsy may be doubly, even triply cursed, according a new theoretical model of the world's most common inherited brain disorder. [ + ]
BioProspect teams with US company in screening deal
Queensland-based BioProspect has formed a collaboration with US company Apath to screen BioProspect's natural plant extract library for potential antiviral therapeutics for hepatitis C virus (HCV) and other pathogenic viruses. [ + ]
Leptin as a treatment for obesity? Fat chance
The prospect of treating obese humans with leptin, a natural appetite suppressant secreted by fat cells, is looking increasingly slim after a new study by a Melbourne researcher. [ + ]
National award for unlocking mysteries of chemistry
The Royal Australian Chemical Institute (RACI) has announced Associate Professor Roy Tasker from the University of Western Sydney as the new recipient of the Chemical Education Division Medal, the highest award in Australia for chemical education.
[ + ]Autogen says exercise affects genes for diabetes, obesity
Shares in drug discovery company Autogen rose more than 15 per cent today after the company announced that nine new genes involved in diabetes and obesity were affected by exercise. [ + ]
Gradipore cuts staff 15 per cent
A 15 per cent staff cut at Sydney-based listed biotech Gradipore has been given an enthusiastic tick of approval by investors. [ + ]
New brain cells in mice could help eliminate effects of MS
Scientists at St Vincent's Hospital in Sydney have succeeded in creating new brain cells in mice, using adult stem cells, in a move which has the potential to eliminate some effects of multiple sclerosis (MS) and related illnesses.
[ + ]Progen boosts manufacturing arm with new US deal
Brisbane biotech Progen Industries has reinforced the already significant contribution of its contract drug manufacturing arm by signing an agreement with US-based Sequella. [ + ]
Adult stem cells hold promise in future MS therapy
Researchers at Sydney's St Vincent's Hospital have found for the first time that adult stem cells can be differentiated into the white matter forming cells of the brain, the oligodendrocytes. [ + ]
Researcher rues loss as marsupial genome opportunities hop overseas
A proposal for an Australian-based Kangaroo Genome Project has missed out on the latest round of Australian Research Council Research Centres of Excellence Grants, announced late last month. [ + ]
GroPep back in the black
Fulfilling a promise made to shareholders at its annual general meeting in November, Adelaide-based >GroPep has ended 2002 free of debt and with $AUD5.6 million cash in the bank, newly hired CFO Tony Mitchell said today. [ + ]
Australia joins global marine census
Australia will join 20 other nations in a $1 billion, 10-year, global effort to assess the status of marine life worldwide.
[ + ]Found: molecular pathway to switch off auto-immune disease
A University of Queensland team at the Princess Alexandra Hospital is believed to be the first in the world to find a mechanism to turn off an auto-immune disease, once it has started.
[ + ]